← All stocks

Thermo Fisher Scientific

TMO Net selling
CIK 0000097745 #440 in the set updated 17 Sep 2026
Bought (120 mo)
$13.14K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.20B
$38.98M on a plan · $1.04B straight out of an exercise
Sold at will
$120.51M
186 of 1107 sales
Net
−$1.20B
−$120.50M against sales at will

By person

37 insiders · 1,110 transactions
47.8×

Marc N. Casper holds 47.8 times base salary in stock. $85.38M of shares against $1.79M in salary for 2025.

Salary from the company's own proxy. The shares are what Marc N. Casper last reported holding, valued at $614.38, the price Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CASPER MARC N
Chairman & CEO
$684.81M (837) scheduled
−$684.81M
138,969
0.0376%
$85.38M
−58.8%
Stevenson Mark P
Retiring Executive VP & COO
$132.90M (61) scheduled
−$132.90M
67,461
0.0182%
$41.45M
Lagarde Michel
Executive Vice President
$132.44M (46) scheduled
−$132.44M
85,151
0.0230%
$52.32M
Williamson Stephen
Retiring Sr. VP and CFO
$91.59M (42) scheduled
−$91.59M
45,173
0.0122%
$27.75M
+44.8%
Britt Lisa P.
Sr. VP and Chief HR Officer
$27.69M (9) scheduled
−$27.69M
14,391
0.0039%
$8.84M
−16.1%
Herrema Gregory J.
Senior Vice President
$24.10M (10) scheduled
−$24.10M
26,967
0.0073%
$16.57M
−27.1%
Shafer Michael D
Executive Vice President
$23.48M (6) scheduled
−$23.48M
20,204
0.0055%
$12.41M
+22.9%
Boxer Michael A
SVP and General Counsel
$2.10K (1)
$17.96M (6) scheduled
−$17.96M
10,816
0.0029%
$6.65M
Lowery Frederick M.
Executive Vice President
$17.89M (3) scheduled
−$17.89M
15,044
0.0041%
$9.24M
+40.6%
Pettiti Gianluca
President & COO
$11.81M (17) scheduled
−$11.81M
23,216
0.0063%
$14.26M
+89.5%
Jafry Syed A.
Sr. Vice President
$8.51M (7) scheduled
−$8.51M
22,349
0.0060%
$13.73M
+48.6%
MANZI JIM P
Director
$7.44M (17)
−$7.44M
14,807
0.0040%
$9.10M
−61.8%
Durbin Patrick M
Senior Vice President
$6.11M (9) scheduled
−$6.11M
38,868
0.0105%
$23.88M
+48.1%
HORNSTRA PETER E
VP & Chief Accounting Officer
$3.60M (8) scheduled
−$3.60M
17,795
0.0048%
$10.93M
+1.4%
WILVER PETER M
Exec. VP & Chief Admin Officer
$3.04M (2) scheduled
−$3.04M
62,517
0.0169%
$38.41M
−6.8%
Loewald Thomas W
Senior Vice President
$2.11M (3) scheduled
−$2.11M
38,133
0.0103%
$23.43M
+6.5%
Jacks Tyler
Director
$1.42M (2)
−$1.42M
9,462
0.0026%
$5.81M
−8.3%
Holmes Joseph R.
VP & Chief Accounting Officer
$1.37M (7) scheduled
−$1.37M
2,916
0.0008%
$1.79M
+183.3%
HOOGASIAN SETH H
Sr. VP & Retiring Gen. Counsel
$1.23M (2)
−$1.23M
26,530
0.0072%
$16.30M
−3.1%
Shine Daniel P
Senior Vice President
$1.17M (3) scheduled
−$1.17M
20,682
0.0056%
$12.71M
+18.6%
Parrett William G
Director
$421.23K (2)
−$421.23K
11,660
0.0032%
$7.16M
−7.7%
Spar Debora L
Director
$310.85K (3)
−$310.85K
2,610
0.0007%
$1.60M
HARRIS C MARTIN
Director
$183.77K (4)
−$183.77K
9,532
0.0026%
$5.86M
+105.1%
Chai Nelson
Director
$11.04K (2)
$8.45K (1)
+$2.59K
15,316
0.0041%
$9.41M
+59.8%
SPERLING SCOTT M
Director
69,479
0.0188%
$42.69M
−14.7%
LYNCH THOMAS J
Director
10,257
0.0028%
$6.30M
+26.7%
SORENSEN LARS REBIEN
Director
9,233
0.0025%
$5.67M
+41.8%
Shropshire Thomas B Jr.
SVP and General Counsel
6,009
0.0016%
$3.69M
Meyer James
Sr. Vice President & CFO
5,618
0.0015%
$3.45M
−5.1%
WEISLER DION J
Director
5,446
0.0015%
$3.35M
ULLIAN ELAINE
Director
4,706
0.0013%
$2.89M
+56.2%
CHANDY RUBY R
Director
3,463
0.0009%
$2.13M
+166.6%
MULLEN JAMES C
Director
3,393
0.0009%
$2.08M
Keith R. Alexandra
Director
2,602
0.0007%
$1.60M
JOHNSON JENNIFER M
Director
1,403
0.0004%
$861.98K
LEWENT JUDY C
Director
1,290
0.0003%
$792.55K
Lynch Karen S
Director
1,159
0.0003%
$712.07K
Insider
Date
Role
Action
Shares
Price
Amount
Britt Lisa P.
12 Nov 2025
Sr. VP and Chief HR Officer
Sell
1,058
$588.27
$622.14K
Boxer Michael A
10 Mar 2025
SVP and General Counsel
Sell
3,775
$532.53
$2.01M
Chai Nelson
19 Feb 2025
Director
Sell
16
$528.09
$8.45K
Showing 250 of 1,110 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 757
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 59
Sales straight out of an exercise 862
Sales at will 186
Transactions with no price 0
Shares from compensation/vesting 4,449,428
Sales filed before the plan box existed 180
History held since 29 Aug 2016